We are a physician-driven, patient-inspired specialty pharmaceutical company. Our mission is to develop proprietary clinical stage drugs from validated, risk-mitigated compounds that address unmet medical needs or overcome limitations of existing products.
At Afecta, collaboration is in our genes. Our partners and clients have come to us because of our proven track record, unique resources and technologies. We deliver.
Our technologies, resources and expertise allow us to contribute to developing new therapies in many areas of human health.
See what’s happening. Join in. Tell us what you think?
Afecta has proprietary state of the art bioinformatics platforms, databases, molecules, computer assisted modeling/design tools as well as drug delivery technologies.
The most fruitful basis for the discovery of a new drug is to start with an old drug
- Sir James Black, Winner of the 1988 Nobel Prize in Physiology and Medicine.